-
The list of key monitored drugs is adjusted once every three years and 30 varieties are included
Time of Update: 2021-09-12
All provincial health administrative departments shall, based on the 30 drug varieties submitted by the province, include them in the new version of the list of drug varieties, form a provincial-level key monitoring and rational use drug list, and report to the National Health Commission for the record in a timely manner .
-
There are four major things that cannot be done for the collection of unsuccessful varieties to break out of the out-of-hospital market!
Time of Update: 2021-09-12
After the promotion of the centralized procurement policy, the products that did not win the bid almost lost the country's main public hospital sales market .
-
6 substances including MAPA are listed in the management of precursor chemicals
Time of Update: 2021-09-12
According to the content of the announcement, the production, operation, purchase, transportation and import and export activities of six substances shall implement the relevant regulations on non-drug precursor chemicals .
-
Gansu Province: Several Measures to Promote the Inheritance, Innovation and Development of Traditional Chinese Medicine!
Time of Update: 2021-09-12
Provided by the national Chinese herbal medicine production enterprises, continuously strengthen the quality and safety supervision of the whole process from planting to use, improve the quality of Chinese herbal medicines, and promote the high-quality development of the Chinese medicine industry .
-
5 billion new dosage forms of antihypertensive drugs, this pharmaceutical company will win
Time of Update: 2021-09-12
According to data from Mi Nei. com, in 2020, the total sales of valsartan in Chinese urban public hospitals , county-level public hospitals, urban community centers, township health centers (referred to as Chinese public medical institutions) and the terminal valsartan in Chinese urban physical pharmacies will exceed 5 billion yuan.
-
The domestic recombinant insulin Qixiong contends for hegemony, the new force launches new challenges!
Time of Update: 2021-09-12
According to data from Mi Nei. com , in 2020, China’s urban public hospitals, county-level public hospitals, urban community centers, and township health centers (referred to as Chinese public medical institutions) will have a total sales of terminal insulin and similar products of nearly 27 billion yuan in 2020, a year-on-year increase.
-
The severe global drug resistance should limit the abuse of 5 billion cefoperazone and sulbactam!
Time of Update: 2021-09-11
In recent years, China, Europe and the United States have accelerated the approval of new drugs, encouraging the development and marketing of new anti-drug-resistant bacteria drugs .
-
Minister of Health of Belarus: Interested in realizing localized production of Chinese medicine in Belarus
Time of Update: 2021-09-11
Pinevich said that Belarus and China maintain friendly exchanges, which is conducive to the development of pragmatic cooperation between the two countries in the fields of medical and health care .
-
Small pills with great energy, quick-acting heart-relief pills to save the heart at critical moments
Time of Update: 2021-09-11
Like the station staff!Expert Tips: If there is a cardiac arrest and fall to the ground, there is a "golden four-minute" rescue time.
Reminder: As a heart emergency medicine, Suxiao Jiuxin Pills should be taken in the correct way: take 4~6 capsules once a day and take them three times a day .
-
60% increase in distribution rate in key channels! Trax injects new impetus into channel inspections for pharmaceutical companies
Time of Update: 2021-09-10
A world-leading multinational pharmaceutical company is facing the time and cost challenge of channel distribution inspection . A world-leading multinational pharmaceutical company is facing the tim
-
Reference price 338 yuan?
Time of Update: 2021-09-04
On August 17, the Chongqing Medical Insurance Bureau issued the "On the development of the production of endoscopic cutting staples and venous indwelling needles related production enterprises and product information collection work notice ", will be carried out endoscopic cutting stapler and intravenous catheter with a volume of more than Federation of Municipalities and procurement .
-
Third review of the "Physician Law" draft: suggest that doctors should be exempted from responsibility for saving lives outside the hospital
Time of Update: 2021-09-04
Carefully read the "Physician Law (Draft Second Review)", which contains provisions to encourage and support doctors saving people outside the hospital.
-
The price of Northwest benchmark products has risen, and the market has entered an overheating stage!
Time of Update: 2021-09-04
Pharmaceutical Network News August 23, 2021 August 15-August 21, among the 1,587 varieties monitored by the Big Data Center of the Pharmaceutical Industry of Tiandi Yuntu (including the same varietie
-
Plymouth enters the contrast agent market, its first product aims at 1 billion best-selling products
Time of Update: 2021-09-04
com, the terminal contrast agent market for public medical institutions in China will exceed 15 billion yuan in 2020, and currently only two of the top 5 companies are domestic pharmaceutical companies .
-
Why does the nine-valent HPV vaccine increase by 3,000 yuan on the platform about vaccines?
Time of Update: 2021-09-04
A reporter from Beijing Youth Daily saw in a parenting Taobao flagship store that the "Nine-price HPV Cervical Cancer Vaccine Reservation Service" is sold in more than 800 pieces a month.
-
End of the pilot, innovation and start again
Time of Update: 2021-09-04
Subsequently, Yunnan, Shaanxi, Hainan, Guizhou and other provinces (autonomous regions, municipalities) drug regulatory authorities have successively issued the working procedures for the formulation of quality standards for traditional Chinese medicine formula granules and the requirements for application materials, and actively implemented the relevant requirements of the "Announcement" .
-
Re-release the signal of collection of biological drugs!
Time of Update: 2021-09-04
In the list of TOP20 products of terminal western medicines in China's public medical institutions in 2020, human albumin, intravenous human immunoglobulin (pH4), insulin aspart, trastuzumab, bevacizumab and rituximab Other biological drugs are among them .
-
One billion retail oral antithrombotic drugs "emergency"!
Time of Update: 2021-09-04
According to data from Mi Nei, in 2020, the sales volume of terminal antithrombotic drugs in urban physical pharmacies in China will exceed 3 billion yuan .
Sales of terminal antithrombotic drugs in physical pharmacies in Chinese cities in recent years (unit: 100 million yuan) Source: Meinenet.
-
Trax perfect store execution empowers pharmaceutical and health companies to tap the most potential for growth in various markets around the world
Time of Update: 2021-09-03
As it involves multiple levels of evaluation impact and improvement strategies, in order to achieve the consistency of global store management, how to make store digitalization as simple as possible without changing the original store operation and execution methods as much as possible?
-
The national key monitoring catalogue is adjusted every two years, and Chinese medicine companies look to the non-medical insurance market
Time of Update: 2021-08-28
In the new version of the National Medical Insurance Catalogue published in August 2019, all key monitored drugs are transferred, including some varieties with relatively large annual sales, which may have an impact on the production and operation of individual enterprises .
